ArticleAmerican journal of clinical dermatology2024
Comment on "Efficacy and Safety of Brodalumab, an Anti‑interleukin‑17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16‑Week Results of a Randomized Clinical Trial".
Lu-Ying Wang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.